State-of-the-art management of nasopharyngeal carcinoma: current and future directions
about
Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma.Heparanase expression in nasopharyngeal carcinoma inversely correlates with patient survival.Detection of nasopharyngeal carcinoma in Morocco (North Africa) using a multiplex methylation-specific PCR biomarker assay.Epidemiology and Inequality in the Incidence and Mortality of Nasopharynx Cancer in Asia.Development of a non-invasive method, multiplex methylation specific PCR (MMSP), for early diagnosis of nasopharyngeal carcinomaIntegrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma.Salvage surgery for neck residue or recurrence of nasopharyngeal carcinoma after primary radiotherapy: options of surgical methods and regions.Selection of reliable reference genes for gene expression study in nasopharyngeal carcinoma.Targeting tumor hypoxia in nasopharyngeal carcinoma.Critical appraisal of maxillary swing approach for nasopharyngeal carcinoma.Postradiation sarcoma after radiotherapy for nasopharyngeal carcinoma.Radiation-induced squamous cell carcinoma of the nasopharynx after radiotherapy for nasopharyngeal carcinoma.Multivariate analysis of prognostic factors for salvage nasopharyngectomy via the maxillary swing approach.Induction Chemotherapy Has No Prognostic Value in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma and Chronic Hepatitis B Infection in the IMRT Era.ATM, THMS, and RRM1 protein expression in nasopharyngeal carcinomas treated with curative intent.The role of Epstein-Barr virus-encoded microRNA BART7 status of resection margins in the prediction of local recurrence after salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma.Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Regional Nodal Metastasis in Nasopharyngeal Carcinoma: Correlation with Nodal Staging.Increase in tumour-infiltrating lymphocytes with regulatory T cell immunophenotypes and reduced zeta-chain expression in nasopharyngeal carcinoma patients.The role of plasma Epstein-Barr virus DNA in the management of recurrent nasopharyngeal carcinoma.Prediction of surgical outcome using plasma Epstein-Barr virus dna and (18)F-FDG PET-CT scan in recurrent nasopharyngeal carcinoma.Impact of nodal ratio on survival in recurrent nasopharyngeal carcinoma.Role of surgery in the treatment of osteoradionecrosis and its complications after radiotherapy for nasopharyngeal carcinoma.T4-locally advanced nasopharyngeal carcinoma: prognostic influence of cranial nerve involvement in different radiotherapy techniques.
P2860
Q33916098-33B117C9-ACAF-4662-8175-F48D980ABF2DQ34552759-F54EB095-748B-4965-9C58-FAF2AE0E73ADQ35987088-842F7243-A0BA-4027-8EE2-E15BA10AB596Q36239931-B8DFF5AF-E99D-4F64-A34E-DB3ED4CC59CDQ36373732-1FE3A7EF-391A-4D79-ABF5-4B9FEEB06B17Q36544611-44B8D705-5F56-496D-90ED-7F063ADB4139Q36728237-77F44792-BEB4-4CBD-83E8-D47E388CB030Q37729875-19BC4848-FFCC-4D96-912B-F837EE61CF34Q37959387-11601164-A590-4F56-AE4E-E560DE65F0DDQ37982129-DB4E6B32-768B-4A84-94F4-7AEA0577FACFQ38052477-75B6BDCC-181B-4B77-BDCF-1093C14288ADQ38101530-F4B640C4-DDB7-49FD-874C-11A8B4F3EE45Q38115742-0BFFD908-257B-4562-94C8-0EC1092DC8D9Q40069249-92E71C4D-C0EB-4768-A525-3EF6B7BE6F58Q40254033-21376141-B6F2-47D9-AE6F-3BC9CA6062BFQ41752446-0401F34E-5617-4E09-9E36-CCAA9699BD5AQ43376048-C5021CC3-B966-4E22-B847-E0943947CE98Q44638209-067B638E-070E-4AC8-81AE-787EED3C2D30Q45351163-C78BCBDD-1D25-48C7-AF92-EBF76E973853Q45367060-42A7E90A-DC70-47ED-AC61-E212234FE138Q46563559-7AAB80C7-C68E-49BD-8D74-DD9CF5FFD185Q47909190-EC70088D-34AD-47F1-A1E5-8BD313DD104BQ54377245-2D37E4B8-64C1-487F-951F-952F20E50865
P2860
State-of-the-art management of nasopharyngeal carcinoma: current and future directions
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
State-of-the-art management of nasopharyngeal carcinoma: current and future directions
@ast
State-of-the-art management of nasopharyngeal carcinoma: current and future directions
@en
type
label
State-of-the-art management of nasopharyngeal carcinoma: current and future directions
@ast
State-of-the-art management of nasopharyngeal carcinoma: current and future directions
@en
prefLabel
State-of-the-art management of nasopharyngeal carcinoma: current and future directions
@ast
State-of-the-art management of nasopharyngeal carcinoma: current and future directions
@en
P2860
P356
P1476
State-of-the-art management of nasopharyngeal carcinoma: current and future directions
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602449
P407
P577
2005-03-01T00:00:00Z
2005-03-14T00:00:00Z